Bristol-Myers to pay $1.85 billion in cancer deal with Nektar
Read More
Bagikan Berita Ini
Rabu, 14 Februari 2018
News Business
Bristol-Myers to pay $1.85 billion in cancer deal with Nektar
(Reuters) - Bristol-Myers Squibb Co will pay Nektar Therapeutics $1.85 billion in cash and share purchase for a global development and commercialization deal on a promising Nektar cancer drug, the companies announced on Wednesday.
Bristol-Myers to pay $1.85 billion in cancer deal with Nektar
Read More
Bagikan Berita Ini
Bristol-Myers to pay $1.85 billion in cancer deal with Nektar
Read More
Bagikan Berita Ini
0 Response to "Bristol-Myers to pay $1.85 billion in cancer deal with Nektar"
Posting Komentar